광선각화증 시장 규모는 향후 수년간 비약적인 성장이 전망될 예정입니다. 예측 기간의 성장은 보행, 병용치료의 채용 증가, 비침습적 처치 수요 증가, 원격 피부과의 이용 확대, 광선역학적 요법의 적용 확대, 미용적 성과에 대한 의식 증가, 표적 생물학적 치료의 개발, 신흥국 시장에서의 헬스케어 투자 증가, 조기 발견과 예방에 대한 주목의 고조 등에 기인한다고 생각됩니다. 예측 기간의 주요 동향에는 AI 구동 진단 툴, 병변 해석을 위한 머신러닝, 선진 광선 역학적 치료 시스템, 웨어러블 UV 모니터링 디바이스, 나노 테크놀로지에 기초 약물전달, 개인화 치료를 위한 3D 이미징, 휴대용 가정용 광선 치료 장치, 조기 발견을 위한 바이오센서, 자동 병변 분류 소프트웨어, 하이드로겔 기반 치료 시스템 등이 있습니다.
심한 황갈색 증례 수 증가가 향후 광선각화증 시장의 확대를 견인할 것으로 예측됩니다. 피부열상으로 발적, 통증, 부종, 때로는 수포 형성 등의 증상을 일으킵니다. 정지 대책이 불충분한 것, 자외선량이 피크에 이르는 시간대에 옥외에서의 활동이 늘어나는 것, 기후 변화에 따른 기온의 상승 등의 요인에 의해 일어난다 병변의 형성에 기여합니다. 예를 들어, 2024년 5월 영국에 본부를 둔 자선단체인 흑색종 포커스(Melanoma Focus)는 2022-2023년에 햇볕에 의한 화상으로 병원에 입원한 어린이 89명과 1세 미만 영유아 25명을 포함해 201명이 입원했다고 보고했습니다. 이 자선 단체는 또한 16-65세 영국 성인의 66%가 어린 시절 햇볕에 화상을 입은 경험이 있다고 답했으며, 65%는 물집이 생긴 심한 일광 화상을 한 번 이상 겪었다고 답했으며, 피부가 밝고 창백하거나 하얀 사람일수록 이 수치는 77%까지 증가했습니다.
광선각화증 시장 기업 프로파일은 전암 병변을 보다 효과적으로 표적으로 제거하고, 재발률을 저하시키고, 치료 기간의 단축과 안전성 프로파일의 개선에 의해 환자의 어드히어런스를 향상시키는 국소 연고의 개발에 주력하고 있습니다. 연고는 피부환부에 직접 도포하는 약용 크림 또는 겔이며, 비정상적인 케라티노사이트를 표적으로 하여 전암병변을 치료하는 틸바니블린 등의 유효성분을 포함하고 있습니다. 예를 들어, 2024년 6월 스페인에 본사를 둔 바이오 제약 회사인 Almirall SA는 미국 식품의약국(FDA)으로부터 자사의 약물인 클리시리의 사용 범위를 최대 100cm2까지 확대하는 추가 신약 신청(sNDA)에 대한 승인을 받았습니다. 클리시리(티르바니불린) 1% 연고는 비정상적인 각질 세포의 증식을 방지하여 얼굴이나 두피의 광선각화증(AK) 치료를 위한 전암성 병변의 수와 크기를 효과적으로 감소시키는 미세소관 억제제입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 광선각화증 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인과 억제요인)
- 최종 이용 산업의 분석
- 세계의 광선각화증 시장 : 성장률 분석
- 세계의 광선각화증 시장 실적 : 규모와 성장(2019-2024년)
- 세계의 광선각화증 시장 예측 : 규모와 성장(2024-2029년, 2034년)
- 세계의 광선각화증 전체 시장(TAM)
제6장 시장 세분화
- 세계의 광선각화증 시장 : 치료 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 국소 치료
- 수술 절차
- 광역학 치료
- 기타 치료 유형
- 세계의 광선각화증 시장 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 병원 약국
- 약국 및 소매 약국
- 온라인 제공업체
- 세계의 광선각화증 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 병원
- 피부과 클리닉
- 스파 및 회춘 센터
- 홈케어
- 기타 최종 사용자
- 세계의 광선각화증 시장 : 국소 치료 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 5-플루오로우라실(5-FU)
- 이미퀴모드
- 디클로페낙
- 인제놀 메부테이트
- 레티노이드
- 세계의 광선각화증 시장 : 수술 절차 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 냉동 요법
- 소파술 및 전기 소작
- 절제술
- 세계의 광선각화증 시장 : 광역학 치료 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 아미놀레불린산(ALA) 플러스 라이트 테라피
- 메틸 아미놀레불린산염(MAL) 플러스 라이트 테라피
- 세계의 광선각화증 시장 : 기타 치료 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 레이저 치료
- 화학적 박피
- 복합 요법
제7장 지역별/국가별 분석
- 세계의 광선각화증 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 세계의 광선각화증 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
- 광선각화증 시장 : 경쟁 구도
- 광선각화증 시장 : 기업 프로파일
- Pfizer Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- F. Hoffmann-La Roche AG 개요, 제품 및 서비스, 전략 및 재무 분석
- Merck & Co. Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- AbbVie Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- Sanofi SA 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
- Bristol-Myers Squibb
- Novartis AG
- GSK plc
- Amgen Inc.
- Bausch Health Companies Inc.
- Perrigo Company plc
- Galderma SA
- Incyte Corporation
- Leo Pharma Inc.
- Almirall SA
- Athenex Inc.
- G&E Herbal Biotechnology Co. Ltd.
- Aclaris Therapeutics Inc.
- Biofrontera Inc.
- Hill Dermaceuticals Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 광선각화증 시장(2029년) : 새로운 기회를 제공하는 국가
- 광선각화증 시장(2029년) : 새로운 기회를 제공하는 부문
- 광선각화증 시장(2029년) : 성장 전략
제36장 부록
KTH
Actinic keratosis (AK), also known as solar keratosis, is a common precancerous skin condition caused by prolonged exposure to ultraviolet (UV) radiation from the sun or artificial sources. It leads to rough, scaly, or crusty patches on sun-exposed areas of the skin, such as the face, scalp, hands, and arms. Actinic keratosis is considered an early stage of squamous cell carcinoma (SCC) and requires treatment to prevent progression. Regular skin checks and protection from sun exposure are important for managing and preventing the development of this condition.
The main types of treatment for actinic keratosis include topical treatments, surgical procedures, photodynamic therapy, and other options. Topical treatment typically involves applying creams or ointments directly to the affected skin areas. Distribution channels for these treatments include hospital pharmacies, drug stores, retail pharmacies, and online providers. End-users of these treatments include hospitals, dermatology clinics, spas and rejuvenation centers, home care settings, and others.
The actinic keratosis market research report is one of a series of new reports from The Business Research Company that provides actinic keratosis market statistics, including actinic keratosis industry global market size, regional shares, competitors with an actinic keratosis market share, detailed actinic keratosis market segments, market trends and opportunities, and any further data you may need to thrive in the actinic keratosis industry. This actinic keratosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The actinic keratosis market size has grown steadily in recent years. It will grow from $7.95 billion in 2024 to $8.44 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth during the historic period can be attributed to rising UV radiation exposure, an aging population, increasing awareness of skin cancer, a growing prevalence of actinic keratosis, expanding healthcare infrastructure, higher disposable incomes, supportive government initiatives, and a greater focus on preventive skincare.
The actinic keratosis market size is expected to see exponential growth in the next few years. It will grow to $10.58 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to the emergence of innovative therapies, advancements in AI-powered diagnostic tools, increasing adoption of combination treatments, rising demand for non-invasive procedures, growing use of teledermatology, expanding application of photodynamic therapy, increased awareness of cosmetic outcomes, development of targeted biologic treatments, rising healthcare investment in emerging markets, and a growing focus on early detection and prevention. Major trends in the forecast period include AI-driven diagnostic tools, machine learning for lesion analysis, advanced photodynamic therapy systems, wearable UV monitoring devices, nanotechnology-based drug delivery, 3D imaging for personalized treatments, portable home-based phototherapy devices, biosensors for early detection, automated lesion classification software, and hydrogel-based therapeutic systems.
The growing number of severe sunburn cases is expected to drive the expansion of the actinic keratosis market in the future. Severe sunburns are intense skin burns resulting from excessive exposure to ultraviolet (UV) radiation, which leads to symptoms such as redness, pain, swelling, and occasionally blistering. These sunburns occur due to factors such as prolonged exposure to UV radiation, inadequate sun protection measures, increased outdoor activities during peak UV hours, and rising temperatures linked to climate change. UV radiation from sunburns damages the DNA in skin cells, causing mutations that disrupt normal cell function and contribute to the formation of precancerous lesions, particularly with repeated or extended sun exposure. For example, in May 2024, the UK-based charity Melanoma Focus reported 201 hospital admissions in 2022-23 due to sunburn, including 89 children and 25 infants under one year old. The charity also found that 66% of UK adults aged 16-65 recalled experiencing sunburn as children, with 65% reporting severe sunburn with blisters at least once, a figure that increased to 77% among those with light, pale, or white skin. As a result, the rising prevalence of severe sunburns is contributing to the growth of the actinic keratosis market.
Companies in the actinic keratosis market are focusing on the development of topical ointments that target and eliminate precancerous lesions more effectively, reduce recurrence rates, and improve patient adherence with shorter treatment periods and better safety profiles. These topical ointments are medicated creams or gels applied directly to affected skin areas, containing active ingredients such as tirbanibulin, which works by targeting abnormal keratinocytes to treat precancerous lesions. For instance, in June 2024, Almirall SA, a Spain-based biopharmaceutical company, received approval from the US Food and Drug Administration (FDA) for a supplemental new drug application (sNDA) to extend the use of its drug, Klisyri, to up to 100 cm2. Klisyri (tirbanibulin) 1% ointment is a microtubule inhibitor designed to prevent the proliferation of abnormal keratinocytes, effectively reducing the number and size of precancerous lesions for the treatment of actinic keratosis (AK) on the face or scalp.
In June 2024, Sun Pharmaceutical Industries Limited, an India-based pharmaceutical company, merged with Taro Pharmaceutical Industries Ltd. for $454 million. This merger aims to leverage Taro's expertise in dermatology and pediatrics, as well as its specialty and generic pharmaceuticals and over-the-counter products. Taro Pharmaceutical Industries Ltd, based in Israel, is focused on developing and manufacturing dermatology and topical treatment products, including those for actinic keratosis.
Major players in the actinic keratosis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb, Novartis AG, GSK plc, Amgen Inc., Bausch Health Companies Inc., Perrigo Company plc, Galderma SA, Incyte Corporation, Leo Pharma Inc., Almirall S.A., Athenex Inc., G&E Herbal Biotechnology Co. Ltd., Aclaris Therapeutics Inc., Biofrontera Inc., Hill Dermaceuticals Inc.
North America was the largest region in the actinic keratosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in actinic keratosis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the actinic keratosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The actinic keratosis market consists of revenues earned by entities by providing services such as skin cancer screenings, cryotherapy, laser treatments, patient education programs and other medical procedures or products for prevention and management. The market value includes the value of related goods sold by the service provider or included within the service offering. The actinic keratosis market also includes sales of cryosurgery devices, laser treatment systems, and sunscreen products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Actinic Keratosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on actinic keratosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for actinic keratosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The actinic keratosis market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Treatment Type: Topical Treatment; Surgical Procedure; Photodynamic Therapy; Other Treatment Types
- 2) By Distribution Channels: Hospital Pharmacies; Drug Stores And Retail Pharmacies; Online Providers
- 3) By End-User: Hospitals; Dermatology Clinics; Spas And Rejuvenation Centers; Homecare Settings; Other End-Users
- Subsegments:
- 1) By Topical Treatment: 5-Fluorouracil (5-FU); Imiquimod; Diclofenac; Ingenol Mebutate; Retinoids
- 2) By Surgical Procedure: Cryotherapy; Curettage And Electrodessication; Excision
- 3) By Photodynamic Therapy: Aminolevulinic Acid (ALA) Plus Light Therapy; Methyl Aminolevulinate (MAL) Plus Light Therapy
- 4) By Other Treatment Types: Laser Therapy; Chemical Peels; Combination Therapies
- Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche AG; Merck & Co. Inc.; AbbVie Inc.; Sanofi S.A.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Actinic Keratosis Market Characteristics
3. Actinic Keratosis Market Trends And Strategies
4. Actinic Keratosis Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Actinic Keratosis Growth Analysis And Strategic Analysis Framework
- 5.1. Global Actinic Keratosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Actinic Keratosis Market Growth Rate Analysis
- 5.4. Global Actinic Keratosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Actinic Keratosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Actinic Keratosis Total Addressable Market (TAM)
6. Actinic Keratosis Market Segmentation
- 6.1. Global Actinic Keratosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Topical Treatment
- Surgical Procedure
- Photodynamic Therapy
- Other Treatment Types
- 6.2. Global Actinic Keratosis Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacies
- Drug Stores And Retail Pharmacies
- Online Providers
- 6.3. Global Actinic Keratosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Dermatology Clinics
- Spas And Rejuvenation Centers
- Homecare Settings
- Other End-Users
- 6.4. Global Actinic Keratosis Market, Sub-Segmentation Of Topical Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 5-Fluorouracil (5-FU)
- Imiquimod
- Diclofenac
- Ingenol Mebutate
- Retinoids
- 6.5. Global Actinic Keratosis Market, Sub-Segmentation Of Surgical Procedure, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cryotherapy
- Curettage And Electrodessication
- Excision
- 6.6. Global Actinic Keratosis Market, Sub-Segmentation Of Photodynamic Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Aminolevulinic Acid (ALA) Plus Light Therapy
- Methyl Aminolevulinate (MAL) Plus Light Therapy
- 6.7. Global Actinic Keratosis Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Laser Therapy
- Chemical Peels
- Combination Therapies
7. Actinic Keratosis Market Regional And Country Analysis
- 7.1. Global Actinic Keratosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Actinic Keratosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Actinic Keratosis Market
- 8.1. Asia-Pacific Actinic Keratosis Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Actinic Keratosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Actinic Keratosis Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Actinic Keratosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Actinic Keratosis Market
- 9.1. China Actinic Keratosis Market Overview
- 9.2. China Actinic Keratosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Actinic Keratosis Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Actinic Keratosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Actinic Keratosis Market
- 10.1. India Actinic Keratosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Actinic Keratosis Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Actinic Keratosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Actinic Keratosis Market
- 11.1. Japan Actinic Keratosis Market Overview
- 11.2. Japan Actinic Keratosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Actinic Keratosis Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Actinic Keratosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Actinic Keratosis Market
- 12.1. Australia Actinic Keratosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Actinic Keratosis Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Actinic Keratosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Actinic Keratosis Market
- 13.1. Indonesia Actinic Keratosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Actinic Keratosis Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Actinic Keratosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Actinic Keratosis Market
- 14.1. South Korea Actinic Keratosis Market Overview
- 14.2. South Korea Actinic Keratosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Actinic Keratosis Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Actinic Keratosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Actinic Keratosis Market
- 15.1. Western Europe Actinic Keratosis Market Overview
- 15.2. Western Europe Actinic Keratosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Actinic Keratosis Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Actinic Keratosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Actinic Keratosis Market
- 16.1. UK Actinic Keratosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Actinic Keratosis Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Actinic Keratosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Actinic Keratosis Market
- 17.1. Germany Actinic Keratosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Actinic Keratosis Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Actinic Keratosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Actinic Keratosis Market
- 18.1. France Actinic Keratosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Actinic Keratosis Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Actinic Keratosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Actinic Keratosis Market
- 19.1. Italy Actinic Keratosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Actinic Keratosis Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Actinic Keratosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Actinic Keratosis Market
- 20.1. Spain Actinic Keratosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Actinic Keratosis Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Actinic Keratosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Actinic Keratosis Market
- 21.1. Eastern Europe Actinic Keratosis Market Overview
- 21.2. Eastern Europe Actinic Keratosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Actinic Keratosis Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Actinic Keratosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Actinic Keratosis Market
- 22.1. Russia Actinic Keratosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Actinic Keratosis Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Actinic Keratosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Actinic Keratosis Market
- 23.1. North America Actinic Keratosis Market Overview
- 23.2. North America Actinic Keratosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Actinic Keratosis Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Actinic Keratosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Actinic Keratosis Market
- 24.1. USA Actinic Keratosis Market Overview
- 24.2. USA Actinic Keratosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Actinic Keratosis Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Actinic Keratosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Actinic Keratosis Market
- 25.1. Canada Actinic Keratosis Market Overview
- 25.2. Canada Actinic Keratosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Actinic Keratosis Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Actinic Keratosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Actinic Keratosis Market
- 26.1. South America Actinic Keratosis Market Overview
- 26.2. South America Actinic Keratosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Actinic Keratosis Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Actinic Keratosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Actinic Keratosis Market
- 27.1. Brazil Actinic Keratosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Actinic Keratosis Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Actinic Keratosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Actinic Keratosis Market
- 28.1. Middle East Actinic Keratosis Market Overview
- 28.2. Middle East Actinic Keratosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Actinic Keratosis Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Actinic Keratosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Actinic Keratosis Market
- 29.1. Africa Actinic Keratosis Market Overview
- 29.2. Africa Actinic Keratosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Actinic Keratosis Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Actinic Keratosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Actinic Keratosis Market Competitive Landscape And Company Profiles
- 30.1. Actinic Keratosis Market Competitive Landscape
- 30.2. Actinic Keratosis Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
31. Actinic Keratosis Market Other Major And Innovative Companies
- 31.1. Bristol-Myers Squibb
- 31.2. Novartis AG
- 31.3. GSK plc
- 31.4. Amgen Inc.
- 31.5. Bausch Health Companies Inc.
- 31.6. Perrigo Company plc
- 31.7. Galderma SA
- 31.8. Incyte Corporation
- 31.9. Leo Pharma Inc.
- 31.10. Almirall S.A.
- 31.11. Athenex Inc.
- 31.12. G&E Herbal Biotechnology Co. Ltd.
- 31.13. Aclaris Therapeutics Inc.
- 31.14. Biofrontera Inc.
- 31.15. Hill Dermaceuticals Inc.
32. Global Actinic Keratosis Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Actinic Keratosis Market
34. Recent Developments In The Actinic Keratosis Market
35. Actinic Keratosis Market High Potential Countries, Segments and Strategies
- 35.1 Actinic Keratosis Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Actinic Keratosis Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Actinic Keratosis Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
